registered   |   log in
  中文

mxene academic

 
contact us

hotline:

17715390137

Tel/Wechat:

  18101240246 (Technology)

0512-68565571

Emailmxenes@163.com (Sales Engineer)bkxc.bonnie@gmail.com

Scan the code to follow or search the official account on WeChat: 

2D Materials Fronrier After paying attention, 

click on the lower right corner to contact us, 

Enter enterprise WeChat.

Professional Services Online

mxene academic
position: home > mxene academic > mxene other fields

IF: 20.3! | Lymphatic Biomimetic Scaffold Regulates Osteoporosis Bone Repair

source:material synthesis Views:13time:2026-02-25material synthesis: 1092348845

已传文件:photo/1771980306.png

Abstract:

This study focuses on the need for osteoporotic bone repair, incorporating lymphatic regulation into the design of biomimetic scaffolds to construct a repair system capable of coordinated coupling of bone, blood vessel, and lymphangiogenesis. It elucidates the central regulatory role of HIF-1α-mediated mitochondrial reprogramming and establishes a novel organoid model for bone regeneration research.


Traditional views hold that bone tissue does not contain lymphatic vessels, but recent research has overturned this notion, demonstrating that lymphatic vessels play a key role in bone regeneration. An efficient bone repair process relies on the synergistic interaction of osteogenesis, angiogenesis, and lymphangiogenesis.


Main Content

Develop 3D-printed bionic scaffolds and investigate their recruitment and regulatory effects on bone marrow mesenchymal stem cells, vascular endothelial cells, and lymphatic endothelial cells; verify the bone repair effect of the scaffolds in osteoporotic bone defect models; and analyze the molecular regulatory mechanisms mediated by the HIF-1α signaling pathway through transcriptomics.


Research Design

Prepare GelMA/ICA@MSN/HAp 3D-printed biomimetic scaffolds; evaluate the effects of the scaffolds on the migration, proliferation, and directional differentiation of relevant cells in vitro; establish an osteoporotic bone defect animal model for in vivo experiments; and use transcriptomic analysis to identify the core regulatory pathways.


Results

The scaffold possesses good biocompatibility and biodegradability, allowing for the stable release of cytokines; in vitro, it can promote the migration, proliferation, and lineage-specific differentiation of three target cell types; in vivo, it can significantly enhance new bone formation while promoting vascular remodeling and lymphatic maturation, and upregulate regulatory factors related to osteogenesis as well as vascular and lymphangiogenesis. Activation of the HIF-1α signaling pathway is a key factor, with lymphatic endothelial cells mediating mitochondrial metabolic reprogramming through this pathway, thereby promoting angiogenesis and osteogenesis.


Original Source

1. Journal: Bioactive Materials
2. Publication Date: 2025-11-04
3. DOI: 10.1016/j.bioactmat.2025.10.041
4. Authors: Weipeng Sun, Qing Lin, Biyi Zhao, Minying Li, Jiacong Xiao, Xueshan Jin, Jinfu Liu, Yifei Wang, Ronghua Zhang, Xiaoyun Li, Ziwei Jiang



 

Reminder: Beijing Beike New Material Technology Co., Ltd. supplies products only for scientific research, not for humans
All rights reserved © 2019 beijing beike new material Technology Co., Ltd 京ICP备16054715-2号
advisory
phone
Email:mxenes@163.com
Tel:+86-17715390137
scan

scan
WeChat